GATA3 is not a diagnostic biomarker of central nervous system paragangliomas
Hum Pathol
.
2021 Dec:118:86-87.
doi: 10.1016/j.humpath.2021.01.004.
Epub 2021 Jan 29.
Authors
Arnault Tauziède-Espariat
1
,
Leïla Mehdi
2
,
Albane Gareton
2
,
Annie Laquerrière
3
,
Homa Adle-Biassette
4
,
Marc Polivka
4
,
Dominique Cazals-Hatem
5
,
Pascale Varlet
2
,
Emmanuèle Lechapt-Zalcman
2
Affiliations
1
Department of Neuropathology, Sainte-Anne Hospital, GHU Paris Neurosciences, Paris 75014, France. Electronic address:
[email protected]
.
2
Department of Neuropathology, Sainte-Anne Hospital, GHU Paris Neurosciences, Paris 75014, France.
3
Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Department of Pathology, Rouen 76000, France.
4
Department of Pathology, Lariboisière Hospital, APHP, Paris 75475, France.
5
Department of Pathology, Beaujon Hospital, APHP, Clichy 92110, France.
PMID:
33524437
DOI:
10.1016/j.humpath.2021.01.004
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
Central Nervous System
Central Nervous System Neoplasms*
GATA3 Transcription Factor
Humans
Paraganglioma* / diagnosis
Substances
Biomarkers
GATA3 Transcription Factor
GATA3 protein, human